# A Trial of HBM9378 in Healthy Chinese Subjects

> **NCT05790694** · PHASE1 · COMPLETED · sponsor: **Harbour BioMed (Guangzhou) Co. Ltd.** · enrollment: 50 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** HBM9378 (SKB378) Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05790694
- **Lead sponsor:** Harbour BioMed (Guangzhou) Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-23
- **Primary completion:** 2023-10-24
- **Final completion:** 2023-10-24
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05790694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05790694, "A Trial of HBM9378 in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05790694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*